TapewireFind a company

person · Reporting owner

Mamoura Diversified Global Holding PJSC

Disclosed activity across 6 companies

Tapewire entity
12299
SEC CIK
0001419351

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ADVANCED MICRO DEVICES INCAMD · Entity 2796Director · 10% ownerMarch 03, 2017March 06, 2017
MidCap Apollo Institutional Private LendingNONE · Entity 7525110% ownerJune 14, 2024September 11, 2025
RECURSION PHARMACEUTICALS, INC.RXRX · Entity 100810% ownerMarch 02, 2023March 03, 2023
Virgin Orbit Holdings, Inc.VORB · Entity 11456910% ownerDecember 30, 2021January 10, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ADVANCED MICRO DEVICES INC

Report date March 03, 2017 · Filed March 06, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote96,906,166 Reported balance After 2017-03-03 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2017-03-03 · Sale · Disposed 45,000,000 · Balance 96,906,166

F1: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

Filing footnotes · ownership attribution and instrument terms

F1: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

MidCap Apollo Institutional Private Lending

Report date June 14, 2024 · Filed September 11, 2025

Jointly reported with Mubadala Investment Co PJSC, MIC Capital Management 85 RSC Ltd

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Shares of Beneficial InterestSEC Table I · non-derivativeIndirectSee Footnote13,788,414 Reported balance After 2024-06-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2024-06-14 · Purchase · Acquired 1,667,108 · Balance 13,788,414

F1: Amount reflects beneficial ownership of the Reporting Persons following the purchase of the common shares of beneficial interest ("Common Shares") of MidCap Apollo Institutional Private Lending reported herein and does not reflect a subsequent purchase that was previously reported.

F2: Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Filing footnotes · ownership attribution and instrument terms

F1: Amount reflects beneficial ownership of the Reporting Persons following the purchase of the common shares of beneficial interest ("Common Shares") of MidCap Apollo Institutional Private Lending reported herein and does not reflect a subsequent purchase that was previously reported.

F2: Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

RECURSION PHARMACEUTICALS, INC.

Report date March 02, 2023 · Filed March 03, 2023

Jointly reported with Mubadala Investment Co PJSC

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee Explanation of Responses12,985,927 Reported balance After 2023-03-02 transaction · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · 2023-03-02 · Purchase · Acquired 66,822 · Balance 12,985,927

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2: Consists of 12,985,927 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Class A Common StockSEC Table I · non-derivativeIndirectSee Explanation of Responses7,062,869 Reported balance Holding disclosure · report date 2023-03-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 7,062,869

F3: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2: Consists of 12,985,927 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F3: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Virgin Orbit Holdings, Inc.

Report date December 30, 2021 · Filed January 10, 2022

Jointly reported with Fifteenth Investment Co LLC, Mubadala Investment Co PJSC

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stockSEC Table I · non-derivativeDirect60,175,111 Reported balance Holding disclosure · report date 2021-12-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 60,175,111

F1: Fifteenth Investment Company LLC is the record holder of these shares. Mamoura Diversified Global Holding PJSC directly or indirectly wholly owns Fifteenth Investment Company LLC. Mamoura Diversified Global Holding PJSC is a wholly-owned subsidiary of Mubadala Investment Company PJSC. As a result, Mamoura Diversified Global Holding PJSC and Mubadala Investment Company PJSC may be deemed to have beneficial ownership of the shares directly held by Fifteenth Investment Company LLC.

Filing footnotes · ownership attribution and instrument terms

F1: Fifteenth Investment Company LLC is the record holder of these shares. Mamoura Diversified Global Holding PJSC directly or indirectly wholly owns Fifteenth Investment Company LLC. Mamoura Diversified Global Holding PJSC is a wholly-owned subsidiary of Mubadala Investment Company PJSC. As a result, Mamoura Diversified Global Holding PJSC and Mubadala Investment Company PJSC may be deemed to have beneficial ownership of the shares directly held by Fifteenth Investment Company LLC.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Blue Owl Technology Finance Corp. II

Report date March 24, 2025 · Filed March 27, 2025

Jointly reported with Mubadala Investment Co PJSC, MIC Capital Management 85 RSC Ltd, MIC Capital Management 93 RSC Ltd

Section 16 reporting ended · disclosed 2025-03-27. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Explanation of Responses0 Reported balance After 2025-03-24 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-03-24 · Other · Disposed 31,965,863.918 · Balance 0

F1: As of March 24, 2025, Blue Owl Technology Finance Corp. ( the "Issuer"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation ("OTF II"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF ("Merger Sub"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 ("Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the "Initial Merger"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the "Merger").

F2: The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger.

F3: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: As of March 24, 2025, Blue Owl Technology Finance Corp. ( the "Issuer"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation ("OTF II"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF ("Merger Sub"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 ("Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the "Initial Merger"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the "Merger").

F2: The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger.

F3: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Endeavor Group Holdings, Inc.

Report date March 24, 2025 · Filed March 27, 2025

Jointly reported with Mubadala Investment Co PJSC

Section 16 reporting ended · disclosed 2025-03-27. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee Footnote0 Reported balance After 2025-03-24 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-03-24 · Other · Disposed 2,232,747 · Balance 0

F1: On March 24, 2025, the previously announced acquisition of the Issuer was completed pursuant to the terms of the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), by and among the Issuer, Wildcat EGH Holdco, L.P., an affiliate of Silver Lake Group, L.L.C., and other parties thereto. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $27.50 in cash, without interest and subject to applicable withholding taxes, other than with respect to certain shares of the Issuer's common stock.

F2: Reflects securities held directly by Fifteenth Investment Company LLC, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Filing footnotes · ownership attribution and instrument terms

F1: On March 24, 2025, the previously announced acquisition of the Issuer was completed pursuant to the terms of the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), by and among the Issuer, Wildcat EGH Holdco, L.P., an affiliate of Silver Lake Group, L.L.C., and other parties thereto. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $27.50 in cash, without interest and subject to applicable withholding taxes, other than with respect to certain shares of the Issuer's common stock.

F2: Reflects securities held directly by Fifteenth Investment Company LLC, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 29, 2025 Filed Jul 31, 2025 23:12 UTC MidCap Apollo Institutional Private Lending NONE · Entity 75251 PurchaseCommon shares of beneficial interest 773,328 $24.16 $18,683,604.48
Disclosure

SEC source: 0000950170-25-101063 · ownership.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

MIC Capital Management 85 RSC Ltd · CIK 0002006022 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 14,561,742

F1 · ownership.nature: Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Read SEC document
March 24, 2025 Filed Mar 27, 2025 16:37 UTC Blue Owl Technology Finance Corp. II NONE · Entity 81482 OtherCommon Stock 31,965,863.918 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-046148 · ownership.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · Former 10% Owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · Former 10% Owner

MIC Capital Management 85 RSC Ltd · CIK 0002006022 · Former 10% Owner

MIC Capital Management 93 RSC Ltd · CIK 0002063187 · Former 10% Owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

F1 · kind: As of March 24, 2025, Blue Owl Technology Finance Corp. ( the "Issuer"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation ("OTF II"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF ("Merger Sub"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 ("Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the "Initial Merger"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the "Merger").

F2 · kind: The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger.

F1 · price: As of March 24, 2025, Blue Owl Technology Finance Corp. ( the "Issuer"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation ("OTF II"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF ("Merger Sub"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 ("Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the "Initial Merger"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the "Merger").

F1 · ownership.nature: As of March 24, 2025, Blue Owl Technology Finance Corp. ( the "Issuer"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation ("OTF II"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF ("Merger Sub"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 ("Merger Agreement"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the "Initial Merger"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the "Merger").

F2 · ownership.nature: The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger.

F3 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Read SEC document
March 24, 2025 Filed Mar 27, 2025 06:18 UTC Endeavor Group Holdings, Inc. EDR · Entity 11600 OtherClass A Common Stock 2,232,747 $27.50 $61,400,542.50
Disclosure

SEC source: 0000950170-25-045701 · ownership.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · See Remarks

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · kind: On March 24, 2025, the previously announced acquisition of the Issuer was completed pursuant to the terms of the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), by and among the Issuer, Wildcat EGH Holdco, L.P., an affiliate of Silver Lake Group, L.L.C., and other parties thereto. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $27.50 in cash, without interest and subject to applicable withholding taxes, other than with respect to certain shares of the Issuer's common stock.

F2 · ownership.nature: Reflects securities held directly by Fifteenth Investment Company LLC, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Read SEC document
June 14, 2024 Filed Sep 11, 2025 20:10 UTC MidCap Apollo Institutional Private Lending NONE · Entity 75251 PurchaseCommon Shares of Beneficial Interest 1,667,108 $25.95 $43,261,452.60
Disclosure

SEC source: 0000950170-25-114223 · ownership.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

MIC Capital Management 85 RSC Ltd · CIK 0002006022 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 13,788,414

F1 · balance_after: Amount reflects beneficial ownership of the Reporting Persons following the purchase of the common shares of beneficial interest ("Common Shares") of MidCap Apollo Institutional Private Lending reported herein and does not reflect a subsequent purchase that was previously reported.

F2 · ownership.nature: Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:09 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 66,822 $7.82 $522,354.26
Disclosure

SEC source: 0001839882-23-005947 · rxrx-form4_030223.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,985,927

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,985,927 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 16:05 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 48,867 $7.94 $388,082.17
Disclosure

SEC source: 0001387131-23-002722 · rxrx-form4_030123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,919,105

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,919,105 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 16:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 815 $7.97 $6,495.55
Disclosure

SEC source: 0001387131-23-002678 · rxrx-form4_022823.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,870,238

F1 · ownership.nature: Consists of 12,870,238 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F3 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F4 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 27, 2023 Filed Feb 28, 2023 16:14 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 52,500 $7.69 $403,725.00
Disclosure

SEC source: 0001387131-23-002560 · rxrx-form4_022723.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,869,423

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.57 to $7.81, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,869,423 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 16:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 109,118 $7.64 $833,552.40
Disclosure

SEC source: 0001839882-23-004972 · rxrx-form4_022423.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,816,923

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.56 to $7.86, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,816,923 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 23, 2023 Filed Feb 24, 2023 16:08 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 51,864 $7.79 $403,792.36
Disclosure

SEC source: 0001387131-23-002375 · rxrx-form4_022323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,707,805

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.72 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,707,805 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 16:26 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 50,941 $7.83 $399,015.76
Disclosure

SEC source: 0001387131-23-002324 · rxrx-form4_022323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,655,941

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.69 to $7.94, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,655,941 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 16:07 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 94,418 $7.74 $731,125.78
Disclosure

SEC source: 0001387131-23-002285 · rxrx-form4_022123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,605,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.65 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,605,000 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 16:07 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 63,382 $7.71 $488,985.79
Disclosure

SEC source: 0001387131-23-002254 · rxrx-form4_021723.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,510,582

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.58 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,510,582 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 17:27 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 42,682 $7.90 $337,042.68
Disclosure

SEC source: 0001387131-23-002226 · rxrx-form4_021623.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,447,200

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,447,200 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 14, 2023 Filed Feb 15, 2023 16:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 6,300 $7.95 $50,059.80
Disclosure

SEC source: 0001839882-23-003873 · rxrx-form4_021323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,404,518

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,404,518 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 13, 2023 Filed Feb 14, 2023 16:10 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 32,474 $7.97 $258,837.26
Disclosure

SEC source: 0001839882-23-003743 · rxrx-form4_021323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,398,218

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,398,218 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 10, 2023 Filed Feb 13, 2023 16:41 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 11,000 $7.98 $87,807.50
Disclosure

SEC source: 0001387131-23-001898 · rxrx-form4_021023.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,365,744

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,365,744 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 16:07 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 600 $7.97 $4,782.00
Disclosure

SEC source: 0001839882-23-002830 · rxrx-form4_020123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,354,744

F1 · ownership.nature: Consists of 12,354,744 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F3 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F4 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 26, 2023 Filed Jan 27, 2023 16:27 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 7,886 $7.99 $63,005.99
Disclosure

SEC source: 0001387131-23-000851 · rxrx-form4_012623.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,354,144

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,354,144 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 25, 2023 Filed Jan 26, 2023 16:11 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 24,526 $7.88 $193,267.33
Disclosure

SEC source: 0001839882-23-001552 · rxrx-form4_012523.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,346,258

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $7.75 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,346,258 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 10, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 69,518 $7.72 $536,845.80
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 11

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,321,732

F1 · date: This is an inadvertent late filing due to an administrative error.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $8.00, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 09, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 76,046 $7.64 $580,839.35
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 10

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,252,214

F1 · date: This is an inadvertent late filing due to an administrative error.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.43 to $8.00, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 06, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 68,953 $7.41 $510,610.76
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 9

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,176,168

F1 · date: This is an inadvertent late filing due to an administrative error.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $8.00, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 05, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 80,035 $7.38 $590,554.25
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 8

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,107,215

F1 · date: This is an inadvertent late filing due to an administrative error.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.75, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 04, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 91,892 $7.80 $716,877.06
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 7

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,027,180

F1 · date: This is an inadvertent late filing due to an administrative error.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.88, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
January 03, 2023 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 141,646 $7.50 $1,063,010.74
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 6

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,935,288

F1 · date: This is an inadvertent late filing due to an administrative error.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.37 to $7.83, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 30, 2022 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 99,754 $7.55 $753,621.52
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 5

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,793,642

F1 · date: This is an inadvertent late filing due to an administrative error.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.72, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 29, 2022 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 84,622 $7.71 $652,774.11
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 4

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,693,888

F1 · date: This is an inadvertent late filing due to an administrative error.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.91, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 28, 2022 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 71,299 $7.18 $511,898.30
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 3

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,609,266

F1 · date: This is an inadvertent late filing due to an administrative error.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.32, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 27, 2022 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 145,652 $7.24 $1,054,403.96
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 2

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,537,967

F1 · date: This is an inadvertent late filing due to an administrative error.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.12 to $7.61, inclusive.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 23, 2022 Filed Jan 13, 2023 16:19 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 100,378 $7.52 $754,420.97
Disclosure

SEC source: 0001387131-23-000335 · rxrx-form4_011123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,392,315

F1 · date: This is an inadvertent late filing due to an administrative error.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.70, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (12) to this Form4.

F13 · ownership.nature: Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
October 27, 2022 Filed Oct 31, 2022 16:08 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 GrantClass A Common Stock 2,551,020 $9.80 $24,999,996.00
Disclosure

SEC source: 0001387131-22-010982 · rxrx-form4_102722.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 11,291,937

F1 · shares: On October 24, 2022, Recursion Pharmaceuticals, Inc. (the "Issuer") entered into a securities purchase agreement with Fifteenth Investment Company LLC, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $24,999,996.00, 2,551,020 shares of Class A Common Stock, $0.00001 par value per share (the "PIPE Shares") of the Issuer's common stock at a price of $9.80 per share.

F2 · ownership.nature: Consists of (i) 11,291,937 shares held of record by Fifteenth Investment Company LLC and (ii) 0 shares held of record by Thirty Fifth Investment Company LLC, as a result of a transfer of 5,963,140 shares to Fifteenth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionSeries D Convertible Preferred Stock · Derivative 5,963,140 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · derivative · entry 9

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,963,140 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · derivative.exercise_date: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · derivative.expiration_date: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F2 · ownership.nature: Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionSeries D Convertible Preferred Stock · Derivative 745,392 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · derivative · entry 8

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

Underlying: Class A Common Stock · 745,392 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · derivative.exercise_date: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F8 · derivative.expiration_date: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionSeries C Convertible Preferred Stock · Derivative 2,307,475 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · derivative · entry 7

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

Underlying: Class A Common Stock · 2,738,824 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

F7 · price: The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

F7 · derivative.exercise_date: The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

F7 · derivative.expiration_date: The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionSeries B Convertible Preferred Stock · Derivative 3,578,653 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · derivative · entry 6

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

Underlying: Class A Common Stock · 3,578,653 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F6 · price: The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F6 · derivative.exercise_date: The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F6 · derivative.expiration_date: The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionClass A Common Stock 5,963,140 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · nonDerivative · entry 5

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 8,740,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F2 · ownership.nature: Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionClass A Common Stock 745,392 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · nonDerivative · entry 3

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 7,062,869

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · price: The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionClass A Common Stock 2,738,824 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · nonDerivative · entry 2

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 6,317,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · price: The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 20, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 ConversionClass A Common Stock 3,578,653 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 3,578,653

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

F1 · ownership.nature: MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 17:06 UTC RECURSION PHARMACEUTICALS, INC. RXRX · Entity 1008 PurchaseClass A Common Stock 2,777,777 $18.00 $49,999,986.00
Disclosure

SEC source: 0001387131-21-004685 · rxrx-form4_041621.xml · nonDerivative · entry 4

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 2,777,777

F2 · ownership.nature: Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F3 · ownership.nature: On April 16, 2021, Fifteenth Investment Company LLC acquired 2,777,777 Class A Shares at a price of $18 per share in connection with Recursion Pharmaceutical, Inc.'s (the "Issuer") initial public offering.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 03, 2017 Filed Mar 6, 2017 15:00 UTC ADVANCED MICRO DEVICES INC AMD · Entity 2796 SaleCommon Stock 45,000,000 $13.63 $613,350,000.00
Disclosure

SEC source: 0000947871-17-000192 · ss33235_4.xml · nonDerivative · entry 1

MUBADALA DEVELOPMENT CO PJSC · CIK 0001419351 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 96,906,166

F1 · ownership.nature: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

Read SEC document
August 30, 2016 Filed Sep 2, 2016 10:03 UTC ADVANCED MICRO DEVICES INC AMD · Entity 2796 GrantWarrant (right to buy) · Derivative 75,000,000 Not disclosed Strike: $5.98 Not disclosed
Disclosure

SEC source: 0000947871-16-001474 · ss8835_4.xml · derivative · entry 1

MUBADALA DEVELOPMENT CO PJSC · CIK 0001419351 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 75,000,000

Underlying: Common Stock · 75,000,000 shares

Expires 2020-02-29

F2 · price: The warrants were granted to a subsidiary of the Reporting Person as part of the consideration for a commercial agreement between the issuer and such subsidiary and were subsequently transferred to the Reporting Person by such subsidiary (see Exhibit 10.1 of AMD's Current Report on Form 8-K, filed on August 31, 2016).

F1 · derivative.exercise_date: The warrant became exercisable with respect to 50,000,000 shares of common stock of the issuer upon issuance of the warrant, however is not exercisable with respect to 25,000,000 shares of common stock of the issuer until August 30, 2017. Additionally, the holder of the warrants may not exercise the warrant if such exercise would cause the holder of such warrants to beneficially own more than 19.99% of the outstanding common stock of the issuer.

F3 · ownership.nature: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

Read SEC document
March 07, 2014 Filed Mar 10, 2014 20:19 UTC ADVANCED MICRO DEVICES INC AMD · Entity 2796 OtherWarrant (right to buy) · Derivative 35,000,000 Not disclosed Strike: $0.01 Not disclosed
Disclosure

SEC source: 0000947871-14-000136 · ss205384_4.xml · derivative · entry 2

MUBADALA DEVELOPMENT CO PJSC · CIK 0001419351 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 35,000,000 shares

Expires 2019-03-02

F2 · price: The warrants were granted to the Reporting Person in conjunction with a joint venture agreement entered into on March 2, 2009 (see Exhibit 10.1 of AMD's Current Report on Form 8-K, filed on October 16, 2008).

F1 · ownership.nature: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

Read SEC document
March 07, 2014 Filed Mar 10, 2014 20:19 UTC ADVANCED MICRO DEVICES INC AMD · Entity 2796 Exercise / conversionCommon Stock 34,906,166 $0.01 $349,061.66
Disclosure

SEC source: 0000947871-14-000136 · ss205384_4.xml · nonDerivative · entry 1

MUBADALA DEVELOPMENT CO PJSC · CIK 0001419351 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 141,906,166

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.